progress against HIV: the need for new treatments for AIDS is more urgent than ever

Article Abstract:

In excess of 100 new medicines against AIDS and AIDS-related conditions are currently being tested in various clinical trials.

Brief Article

---

Slimy business-the biotechnology of biofilms

Article Abstract:

Researchers in biotechnology sector are gathering necessary data to tackle the problem of biofilms by developing antimicrobial agents with novel mechanisms of action. Scientists are beginning to get a handle on the phenotypic differences between bacteria in biofilms and those same species in the planktonic state.

General services, Science & research, Drugs, Research, Biotechnology industry, Biotechnology industries, Company systems management, Information management, Microbial mats

---

Moving goalposts-regulatory oversight of antibacterial drugs

Article Abstract:

The uncertainty concerning the regulation of antimicrobial drug trials might be suppressing investment in infectious disease treatments. The pharma companies feel that commitment from both industry and regulatory agencies would be critical in forming new guidelines and rules for antibacterial drugs for fighting against infectious diseases.

Legal issues & crime, Government regulation (cont), Government regulation, Legal/Government Regulation, Laws, regulations and rules, Pharmaceutical industry

Similar abstracts:

• Abstracts: Pre-empting implementation barriers: Foundations, processes and actions - the need for internal relationships
• Abstracts: Final code sec. 894 regulations: treaty benefits for hybrid entity payments. Tax Court attributes contract manufacturer's activities to principal
• Abstracts: CAncer multidrug resistance: progress in understanding the molecular basis drug resistance in cancer promises more effective treatments

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.